Letter: lipid-lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B-more evidence is needed. Authors' reply
- PMID: 28901569
- DOI: 10.1111/apt.14282
Letter: lipid-lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B-more evidence is needed. Authors' reply
Comment on
-
Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriers.Aliment Pharmacol Ther. 2017 Sep;46(6):599-604. doi: 10.1111/apt.14218. Epub 2017 Jul 13. Aliment Pharmacol Ther. 2017. PMID: 28707319
-
Letter: lipid-lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B-more evidence is needed.Aliment Pharmacol Ther. 2017 Oct;46(8):769-770. doi: 10.1111/apt.14266. Aliment Pharmacol Ther. 2017. PMID: 28901572 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources